Celltrion
068270.KS
#724
Rank
A$43.69 B
Marketcap
$213.20
Share price
0.05%
Change (1 day)
0.13%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.50

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $4.78. In 2022 the company made an earnings per share (EPS) of $4.66 a decrease over its 2021 EPS that were of $5.53.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.50-3.41%
2022$4.66-15.84%
2021$5.5312.77%
2020$4.9070.79%
2019$2.8715.63%
2018$2.48-33.13%
2017$3.71141.17%
2016$1.548.28%
2015$1.4211.28%
2014$1.2816.37%
2013$1.10-67.42%
2012$3.3784.22%
2011$1.8362.13%
2010$1.1380.61%
2009$0.63-559.63%
2008-$0.14-123.16%
2007$0.59